SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (26752)12/4/1998 7:56:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 32384
 
You were talking about my "slam dunk" prediction
>>Also with the FDA being so lenient and still giving Lgnd a hard time is not a good indicator that their drugs and science are the "Slam Dunks" that Henry predicts.>>
Message 6670414
I didn't say that ONTAK was a "slam dunk" before the meeting (and of course ONTAK was aquired, not developed by LGND), although a 14-0 vote for approval is a pretty good indication that the drug will be approved.